HomeCompareISDAF vs MRK

ISDAF vs MRK: Dividend Comparison 2026

ISDAF yields 7.16% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISDAF wins by $51490.44M in total portfolio value
10 years
ISDAF
ISDAF
● Live price
7.16%
Share price
$6.65
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51490.50M
Annual income
$50,145,694,664.04
Full ISDAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ISDAF vs MRK

📍 ISDAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISDAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISDAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISDAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISDAF
Annual income on $10K today (after 15% tax)
$608.88/yr
After 10yr DRIP, annual income (after tax)
$42,623,840,464.43/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ISDAF beats the other by $42,623,832,136.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISDAF + MRK for your $10,000?

ISDAF: 50%MRK: 50%
100% MRK50/50100% ISDAF
Portfolio after 10yr
$25745.28M
Annual income
$25,072,852,231.09/yr
Blended yield
97.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ISDAF
No analyst data
Altman Z
0.3
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISDAF buys
0
MRK buys
0
No recent congressional trades found for ISDAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISDAFMRK
Forward yield7.16%2.76%
Annual dividend / share$0.48$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$51490.50M$56.8K
Annual income after 10y$50,145,694,664.04$9,798.13
Total dividends collected$51398.21M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ISDAF vs MRK ($10,000, DRIP)

YearISDAF PortfolioISDAF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,133$1,432.66$11,206$366.19+$927.00ISDAF
2$16,231$3,248.97$12,650$502.35+$3.6KISDAF
3$25,491$8,124.17$14,407$694.19+$11.1KISDAF
4$51,125$23,849.19$16,585$967.82+$34.5KISDAF
5$144,108$89,404.71$19,342$1,363.89+$124.8KISDAF
6$625,242$471,046.37$22,913$1,947.19+$602.3KISDAF
7$4,489,061$3,820,051.78$27,662$2,823.89+$4.46MISDAF
8$56,068,496$51,265,201.26$34,159$4,173.35+$56.03MISDAF
9$1,256,822,807$1,196,829,516.12$43,337$6,308.80+$1256.78MISDAF
10$51,490,495,068$50,145,694,664.04$56,776$9,798.13+$51490.44MISDAF

ISDAF vs MRK: Complete Analysis 2026

ISDAFStock

Israel Discount Bank Limited, together with its subsidiaries, provides various banking and financial services in Israel, Europe, and North America. The company operates through Retail Banking, Middle Market Banking, Corporate Banking, Financial Operations, Discount Capital, Discount Bancorp, Israel Credit Cards Company, and Other segments. Its personal banking services include checking accounts, deposits and savings products, loans and credit facilities, mortgages, credit cards, capital market products, consulting services, family banking programs, and tax exemption services. The company also provides accounts, credit, funds, credit cards, and loans for small businesses; commercial business products for factories, workshops, service providers, and merchants; corporate, residential and commercial construction, infrastructure, and rental property financing; and personal consulting services for corporations and executives in various fields of investment, inliquidity, and asset management; brokerage and trading services; customized services for diamond traders; and capital market consulting, including foreign trade, documentary collection and credit, foreign guarantee, export financing, online foreign trade, anti money laundering, and mutual fund services. In addition, it offers tools for capital market transactions; provides Israeli private banking, foreign currency, commercial payment, securities custody and execution, capital market advisory, international banking, portfolio management, and online and digital banking services; manages securities investment portfolios for private customers, corporations, not-for-profit organizations, and institutional bodies; and initiates and assists public offerings and private placements, as well as provides underwriting and distribution services. The company operates through a chain of 171 branches in Israel. Israel Discount Bank Limited was incorporated in 1935 and is based in Tel Aviv, Israel.

Full ISDAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ISDAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISDAF vs SCHDISDAF vs JEPIISDAF vs OISDAF vs KOISDAF vs MAINISDAF vs JNJISDAF vs ABBVISDAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.